Interestingly, the activity of SHIP2 is elevated in the kidneys of individuals with T2D receiving sulfonylurea or insulin compared to those who receive metformin or individuals without T2D [85]. This evidence concerns the gene INPPL1 and type 2 diabetes mellitus.